Sequenom is rising like a Phoenix
- Posted by Greg Harmon
- on April 8th, 2015
Sequemon ($SQNM) is a poster child for the dotcom bust. The stock debuted after the February 2000 IPO at 53.25 and rose to over $143 per share the next month, before a full on implosion to under $1 before the end of 2002. It settled in for several years before attempting to rise up after the financial crisis. That attempt failed and it muddled back top the $2 level.
But a funny thing is happening. Its revenue is starting to rise. Its products are making news, and the stock is starting to move back higher. The basing action that took place over the first half of 2014 has given way to a higher base and now a run at resistance. The price is now running towards resistance at 4.05 using rising support over the last 4 months to get there.
A move over 4.05 would carry a target of 5.35. This is just about at the January 2013 high. If you ride the stock from 4.05 to 5.35 and that is all there is that is still a big win. Over 30%. But this stock also has over 17% short interest. Can you say squeeze? Perhaps it is time to stick this one on your radar.
Get my new ebook, Markets for 2015 and Beyond, a long term forecast with all proceeds going to charity.
Want to learn more about Dragonfly Capital Views?
Dragonfly Capital Views Performance Through March 2015 Expiry and sign up here
If you like what you see above sign up for deeper analysis and trading strategy by using the Get Premium button above. As always you can see details of individual charts and more on my StockTwits page.
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.
blog comments powered by Disqus-
Gregory W. Harmon CMT, CFA, has traded since 1986 and held senior positions including Head of Global Trading, Head of Product Development, Head of Strategy and Director of Equity. (More)

